Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: Model selection, reproducibility, and validation

Radiology

Volumn 266, Issue 1, 2013, Pages 271-279

  Gaens, Michaela E ^a,b   Backes, Walter H ^a,b,c   Rozel, Stefan ^a   Lipperts, Matthijs ^a   Sanders, Stefan N ^a   Jaspers, Karolien ^a   Cleutjens, Jacques P M ^a   Sluimer, Judith C ^a,b   Heeneman, Sylvia ^a,b   Daemen, Mat J A P ^a,b   Welten, Rob J T J ^d   Daemen, Jan Willem H ^a   Wildberger, Joachim E ^a,b   Kwee, Robert M ^a   Kooi, M Eline ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CORRELATION COEFFICIENT; DYNAMIC CONTRAST MATERIAL ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPRODUCIBILITY; VALIDATION PROCESS;

AGED; ALGORITHMS; CAROTID ARTERY DISEASES; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84871693174     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120499     Document Type: Article

References (34)

1. Mackay J, Mensah GA. Atlas of heart disease and stroke. Geneva, Switzerland: World Health Organization, 2004.
2. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy: an evidence-based review - report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65(6):794-801. (Pubitemid 41362117)
3. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003;108(15):1772-1778. (Pubitemid 37296082)
4. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340(2):115-126.
5. Sluimer JC, Gasc JM, van Wanroij JL, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008;51(13):1258- 1265. (Pubitemid 351400903)
6. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25(10):2054-2061. (Pubitemid 41416300)
7. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349(24):2316-2325. (Pubitemid 37509739)
8. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003;107(6):851-856. (Pubitemid 36241043)
9. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006;241(2):459-468. (Pubitemid 44632892)
10. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008;59(3):507-514. (Pubitemid 351348221)
11. Calcagno C, Mani V, Ramachandran S, Fayad ZA. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis. Angiogenesis 2010;13(2):87-99.
12. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47(3):601-606. (Pubitemid 34194016)
13. Chen H, Li F, Zhao X, Yuan C, Rutt B, Kerwin WS. Extended graphical model for analysis of dynamic contrast-enhanced MRI. Magn Reson Med 2011;66(3):868-878.
14. Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229(2):340-346. (Pubitemid 37310815)
15. Kwee RM, van Oostenbrugge RJ, Prins MH, et al. Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010;41(7):1389-1393.
16. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361(9352):107-116. (Pubitemid 36092014)
17. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363(9413):915-924. (Pubitemid 38388324)
18. Kwee RM, van Oostenbrugge RJ, Mess WH, et al. Carotid plaques in transient ischemic attack and stroke patients: one-year follow-up study by magnetic resonance imaging. Invest Radiol 2010;45(12):803-809.
19. Kwee RM, Teule GJ, van Oostenbrugge RJ, et al. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging. Stroke 2009;40(12):3718- 3724.
20. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001;104(17):2051-2056. (Pubitemid 33027045)
21. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging 2003;17(4):410-420. (Pubitemid 36396942)
22. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7(1):91-101. (Pubitemid 28365643)
23. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10(3):223-232. (Pubitemid 29463104)
24. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3(1):1-7. (Pubitemid 13129630)
25. Ernst RR. Application of Fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum 1966;37(1):93.
26. Haacke E, Brown RW, Thompson M, Venkatesan R. Magnetic resonance imaging physical principles and sequence design. New York, NY: Wiley, 1999.
27. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56(5):993-1000. (Pubitemid 44691341)
28. Weinmann HJ, Laniado M, Mützel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16(2):167-172.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010;47(8):931-936.
30. Bland JM, Altman DG. Measurement error. BMJ 1996;313(7059):744.
31. Lopata RG, Backes WH, van den Bosch PP, van Riel NA. On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging. Magn Reson Med 2007;58(2):425-429. (Pubitemid 47267663)
32. Jaspers K, Leiner T, Dijkstra P, et al. Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size. Med Phys 2010;37(11):5746-5755.
33. Jaspers K, Aerts HJ, Leiner T, et al. Reliability of pharmacokinetic parameters: small vs. medium-sized contrast agents. Magn Reson Med 2009;62(3):779-787.
34. Aerts HJ, van Riel NA, Backes WH. System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: influence of contrast injection. Magn Reson Med 2008;59(5):1111-1119. (Pubitemid 351590525)